Massive european TB registry aims to map the disease and sharpen treatment
NCT ID NCT07677904
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study collects long-term data from tuberculosis patients across Europe to better understand the disease and its treatment. Researchers track risk factors, diagnostic details, side effects, and outcomes for both drug-sensitive and drug-resistant TB. The goal is to identify what leads to successful treatment and to develop a risk score for mortality. The registry does not test a new drug or intervention but gathers real-world evidence to guide future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could identify factors that improve TB treatment outcomes and help develop a mortality risk score, guiding better care across Europe.
What could go wrong
As an observational registry, it does not test a new treatment, so direct patient benefits are not guaranteed. Data quality depends on consistent reporting from many sites.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Ospedale Sacro Cuore Don Calabria
Negrar, Verona, 37024, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Research Center Borstel, Leibniz Lung Center
Borstel, Schleswig-Holstein, 23845, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••